ArticleJournal of computer-aided molecular design2025

Discovery and validation of pyrrolopyrimidine-based VEGFR2 inhibitors targeting tumor angiogenesis via structure-based virtual screening, quantum chemical analysis, and in vitro assays.

Ahmed I Foudah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.